Pfizer and Moderna vaccines prove 92 percent effective with just 1st dose
Just one dose of the Moderna and Pfizer two-shot coronavirus vaccines is seemingly nearly as good two.
In a study published Thursday in the New England Journal of Medicine, a pair of Canadian-based researchers suggested an amendment to the determined efficacy of the Pfizer vaccines after just one shot. While Pfizer and BioNTech reported their vaccine was just 52.4 percent effective at preventing infection after the first dose, the researchers noted that this data includes results from within the first two weeks after inoculation, "when immunity would have still been mounting." After two weeks, that efficacy mounted to 92.6 percent, matching the first-dose efficacy of 92.1 percent reported from the Moderna vaccine as well. After two doses, the Pfizer vaccine is 95 percent effective, and Moderna's is 94 percent.
The Canadian-based researchers' interpretations of the Pfizer results led them to suggest in the letter that vaccine distributors delay giving people the second dose. This would let distributors get first doses to more at-risk people instead of leaving them "completely unprotected" — something the researchers called "a matter of national security that, if ignored, will certainly result in thousands of COVID-19–related hospitalizations and deaths this winter in the United States."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Another study from January led Pfizer and BioNTech to say Wednesday that they are unsure if the vaccine will be effective at protecting against the B.1.351 variant first found in South Africa. The study published in the New England Journal of Medicine found the vaccine was still capable of neutralizing the virus within the B.1.351 strain, and that trials haven't shown the variant reduces the vaccine's protection in people. Still, the companies may end up creating a booster shot to ensure the vaccine remains effective against the highly transmissible strain.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
Try 6 free issues of The Week Junior
Spark your child's curiosity with The Week Junior - the award-winning current affairs magazine for 8-14s.
By The Week Published
-
Netanyahu's Rafah attack vow snarls truce deal
Speed Read Hours before the truce deal was to be finalized, Netanyahu said Israel will invade Rafah regardless
By Peter Weber, The Week US Published
-
Today's political cartoons - May 1, 2024
Cartoons Wednesday's cartoons - beware of governor, biting debates, and more
By The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published